iDtheinvestordatabase
Home / Directory / Pureos Bioventures
Likely active: portfolio news Oct 2026 Verified 7 Nov 2026

Pureos Bioventures

Swiss biotech venture capital firm that invests in private drug development companies, with an emphasis on next-generation biological drugs and drug formats for severe diseases.

Type
VC firm
Location
Switzerland
Sectors
Healthtech and life sciences, Biotech, Therapeutics

Contacts on file

For Pureos Bioventures, the paid file holds: 4 named decision-makers with roles; LinkedIn page.

Get Europe Complete, $99 Free sample

One-time payment. No subscription. No account.

Notable investments

Alentis TherapeuticsAnaCardioAraris BiotechAdcytherixCallio Therapeutics

Sources

Last checked 7 Nov 2026. Is something wrong? Tell us.

Appears in 6 lists

Biotech investors in Europe (89)Healthtech investors in Europe (291)Venture capital firms in Europe (412)Biotech investors (484)Startup investors in Europe (725)Healthtech investors (1,207)